companydirectorylist.com  Global Business Directories and Company Directories
Search Business,Company,Industry :


Country Lists
USA Company Directories
Canada Business Lists
Australia Business Directories
France Company Lists
Italy Company Lists
Spain Company Directories
Switzerland Business Lists
Austria Company Directories
Belgium Business Directories
Hong Kong Company Lists
China Business Lists
Taiwan Company Lists
United Arab Emirates Company Directories


Industry Catalogs
USA Industry Directories












Company Directories & Business Directories

ACQUI POWERS

KAMLOOPS-Canada

Company Name:
Corporate Name:
ACQUI POWERS
Company Title:  
Company Description:  
Keywords to Search:  
Company Address: 792 Springridge Pl,KAMLOOPS,BC,Canada 
ZIP Code:
Postal Code:
V2E 
Telephone Number: 2503723290 
Fax Number:  
Website:
 
Email:
 
USA SIC Code(Standard Industrial Classification Code):
0 
USA SIC Description:
 
Number of Employees:
 
Sales Amount:
 
Credit History:
Credit Report:
 
Contact Person:
 
Remove my name



copy and paste this google map to your website or blog!

Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples:
WordPress Example, Blogger Example)









Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer

(Any information to deal,buy, sell, quote for products or service)

Your Subject:
Your Comment or Review:
Security Code:



Previous company profile:
ACTION CONSTRUCTION LTD
ACTION CONCRETE PUMPING LTD
ACRES ENTERPRISES LTD
Next company profile:
ACOBY RAINBOW
ACKLANDS-GRAINGER INC
ACKERMANN C W DR SURG










Company News:
  • GRANTS - ALZFORUM
    Please Note: We remove grant postings after 6 months If you would like your listing to be posted longer or taken down sooner, please contact us at grants@alzforum org
  • Troriluzole - ALZFORUM
    Background Troriluzole is a prodrug formulation of riluzole, a medication used to treat amyotrophic lateral sclerosis Following oral administration, aminopeptidases in the blood release riluzole from a tripeptide carrier Unlike riluzole, which must be taken twice a day on an empty stomach, this prodrug requires only once-daily dosing and is unaffected by food
  • APP NL-G-F Knock-in | ALZFORUM
    Summary Untangling the effects of elevated Aβ from those due to APP overexpression is a common challenge when interpreting the phenotypes of APP transgenic mice The APP NL-G-F model avoids potential artifacts introduced by APP overexpression by using a knock-in approach to express APP at wild-type levels and with appropriate cell-type and temporal specificity APP is not overexpressed, but
  • Troculeucel | ALZFORUM
    Background Troculeucel is an immunotherapy consisting of a patient’s own natural killer cells that have been isolated, expanded in the lab, and re-infused The cells are not genetically modified No immunosuppression is required because the cells originate from each patient Troculeucel aims to replenish declining natural killer activity in people with Alzheimer’s disease
  • Tau (DA9) | ALZFORUM
    Alzforum does not sell or distribute antibodies Please contact the source to order or request antibodies
  • Dronabinol - ALZFORUM
    In trials, the most frequent side effects were euphoria, dizziness, sleepiness, nausea and vomiting, abnormal thinking, paranoia, and abdominal pain Risks of dronabinol in older people include delirium, sedation, seizures, blood pressure changes, and increased heart rate It has a low potential for abuse or dependence
  • APPPS1 - ALZFORUM
    Summary APPPS1 mice contain human transgenes for both APP bearing the Swedish mutation and PSEN1 containing an L166P mutation, both under the control of the Thy1 promoter In these mice, expression of the human APP transgene is approximately 3-fold higher than endogenous murine APP Human Aβ42 is preferentially generated over Aβ40, but levels of both increase with age In the brain, the
  • Arimoclomol | ALZFORUM
    Arimoclomol is a hydroxylamine derivative, one of a group of compounds that act as co-inducers of heat-shock protein expression In preclinical work, arimoclomol reduced symptoms and prolonged life in animal models of amyotrophic lateral sclerosis caused by SOD1, FUS, or valosin-containing protein mutation, as well as models of spinal muscular atrophy and NPC (Kieran et al , 2004; Pelaez et al




Business Directories,Company Directories
Business Directories,Company Directories copyright ©2005-2012 
disclaimer